FREMONT, Calif., July 23 /PRNewswire-FirstCall/ —
Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today
announced that it is relocating its corporate headquarters from
Fremont, California to Austin, Texas. Vermillion has
executed a two-year lease for a new principal place of business at
12117 Bee Cave Road, Building Two, Suite 100, Austin, TX 78731. Vermillion will
continue to operate research and development, regulatory and
quality operations in California.
All other functions will be conducted at the Austin offices.
“This move allows us to take advantage of Austin‘s strong talent pool and
cost-effective environment to continue to build the company into a
leading provider of novel, high-value diagnostic tests,” said Gail S. Page, CEO and Chair of the Board
of Directors of Vermillion. “Austin‘s central location also
facilitates more efficient and effective interaction with our
national sales force and our strategic partners on the East Coast,
such as Quest Diagnostics and Johns Hopkins
University, as well as our colleagues on the West Coast,
such as PrecisionMed and Stanford
The move is expected to be completed in September 2010.
Vermillion, Inc. is dedicated to the discovery, development and
commercialization of novel high-value diag